Department of Psychology, Adler University, Chicago, IL, USA.
Parkinson's Disease and Movement Disorders Care Program, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Clin Neuropsychol. 2024 Apr;38(3):783-798. doi: 10.1080/13854046.2023.2261634. Epub 2023 Sep 24.
: To evaluate the latent structure, internal consistency, convergent and discriminant validity, diagnostic accuracy, and criterion validity of the Montreal Cognitive Assessment's auditory items (MoCA-22), which has previously been evaluated in small samples if at all. : 11,284 participants completed the MoCA over 1-2 visits to an Alzheimer Disease Research Center (M = 69.2, M = 15.9, 57.6% women, 92.4% non-Hispanic white). MoCA-22 items were probed with alpha, omega, confirmatory factor analysis, and test-retest correlations. Scores were related to measures of neurocognition, daily functioning, behavioral-psychological symptoms (BPS), and vision performance for convergent-discriminant and criterion validity. Dementia stage was used to calculate area under the receiver operating characteristic (AUC-ROC) curves and cutoffs for mild cognitive impairment (MCI) and dementia. : A single-factor had good fit (CFI = .961; TLI = .945; RMSEA = .061; SRMR = .031), with good internal consistency (Omega total = .83) and test-retest consistency (ICC = .92 at 2.7 years). The strongest convergent correlations were with general cognition and executive functioning, while discriminant validity was demonstrated with its weakest and negative correlations being with BPS. There was strong classification accuracy in distinguishing MCI from normal cognition (AUC = .79; optimal cutoff point < 18), and mild-to-moderate dementia from MCI (AUC = .85; optimal cutoff point < 13). Furthermore, the MoCA-22 had negligible-to-small differences among those with and without vision limitations. : These findings add to the evidence of the MoCA-22's utility and it serves as a useful cognitive screening tool with sound reliability and validity.
为了评估蒙特利尔认知评估的听觉项目(MoCA-22)的潜在结构、内部一致性、收敛和判别效度、诊断准确性和标准效度,该评估之前仅在小样本中进行过评估。11284 名参与者在阿尔茨海默病研究中心进行了 1-2 次 MoCA 测试(M=69.2,M=15.9,57.6%为女性,92.4%为非西班牙裔白人)。MoCA-22 项目通过 alpha、omega、验证性因素分析和测试-重测相关性进行了探测。分数与神经认知、日常功能、行为-心理症状(BPS)以及视觉表现相关,以进行收敛-判别和标准效度分析。痴呆阶段用于计算接收器操作特征(ROC)曲线下面积(AUC-ROC)和轻度认知障碍(MCI)和痴呆的截断值。单一因素具有良好的拟合度(CFI=0.961;TLI=0.945;RMSEA=0.061;SRMR=0.031),具有良好的内部一致性(Omega 总=0.83)和测试-重测一致性(2.7 年后 ICC=0.92)。最强的收敛相关性与一般认知和执行功能相关,而判别效度则通过与 BPS 的最弱和负相关来证明。在区分 MCI 与正常认知(AUC=0.79;最佳截断点<18)和 MCI 与轻度至中度痴呆(AUC=0.85;最佳截断点<13)方面,分类准确性很高。此外,MoCA-22 在有无视力障碍的人群之间的差异可以忽略不计或较小。这些发现增加了 MoCA-22 的效用证据,它是一种可靠和有效的认知筛选工具。